Multidisciplinary frontiers in breast cancer management: a surgeon's perspective.

作者: S. Eva Singletary

DOI: 10.1002/CNCR.22519

关键词: MedicineDigital mammographySurgeryDose-dense chemotherapySystemic therapyCancerBreast cancerDiseaseMetronomic ChemotherapyIntensive care medicineOccult

摘要: The current paradigm of breast cancer management may be altered significantly over the coming years by adoption new treatment schema and devices outside surgical arena. New advances in imaging will improve our ability to detect early-stage disease but also assist monitoring outcomes support development nonsurgical ablation techniques. These advances, some already use, include a 3-dimensional adaptation digital mammography, color Doppler ultrasonography that can visualize neovascularization growing tumors, contrast-enhanced magnetic resonance with improved accuracy for detection occult cancers, specialized approach positron emission tomography designed use on breast, nanoparticle contrast agents visualized near-infrared light. Systemic therapy, which revolutionized last half 20th century, is being reconceptualized, attention turning adjusting timing chemotherapy. Dose-dense regimens are tested, there interest so-called metronomic chemotherapy very low doses given frequent schedule, resulting reduced toxicity reflect an antiangiogenic mode action. Finally, possibility vaccine continues intrigue excite physicians patients alike, promise enlisting body's own immune system seek out destroy cells and/or prevent future disease. It important surgeons stay aware all developments care their true oncologists rather than merely technicians. Cancer 2007. © 2007 American Society.

参考文章(50)
Sardanelli F, Podo F, Iozzelli A, Dolcetti R, Cortesi L, Zuiani C, Caligo Ma, Pensabene M, Bazzocchi M, Bonomo L, Spatti Gb, Canese R, Trecate G, Cirillo S, Petrillo A, Federico M, D'Andrea E, Ferrari S, De Santis M, Cama A, Viel A, Bartolozzi C, Panizza P, Bergonzi S, Bevilacqua G, Morassut S, Mariani-Costantini R, Battista P, D'Agnolo G, Vergnaghi D, Contegiacomo A, Carriero A, Cilotti A, Musumeci R, Veronesi A, Del Maschio A, Romagnoli R, Pasini B, Capuano I, Silingardi, Marini C, Londero, Manuokian S, Grandinetti Ml, Zunnui I, Marra, Costa C, Francescutti Ge, De Giacomi C, Turchett D, Burgazzi Gb, Gustavino C, Natali Pg, Palca G, De Simone T, Centurioni Mg, Crecco M, Coran F, Di Maggio C, Boiocchi M, Martincich L, The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. Journal of Experimental & Clinical Cancer Research. ,vol. 21, pp. 115- 124 ,(2002)
L Norton, Evolving concepts in the systemic drug therapy of breast cancer. Seminars in Oncology. ,vol. 24, ,(1997)
Michael Campoli, Soldano Ferrone, Arnold H. Zea, Paulo C. Rodriguez, Augusto C. Ochoa, Mechanisms of Tumor Evasion Cancer Treatment and Research. ,vol. 123, pp. 61- 88 ,(2005) , 10.1007/0-387-27545-2_3
Judah Folkman, Birgit M. Kräling, Catherine E. Butterfield, Blair Marshall, Timothy Browder, Michael S. O’Reilly, Bin Shi, Antiangiogenic Scheduling of Chemotherapy Improves Efficacy against Experimental Drug-resistant Cancer Cancer Research. ,vol. 60, pp. 1878- 1886 ,(2000)
Heang-Ping Chan, Jun Wei, Berkman Sahiner, Elizabeth A. Rafferty, Tao Wu, Marilyn A. Roubidoux, Richard H. Moore, Daniel B. Kopans, Lubomir M. Hadjiiski, Mark A. Helvie, Computer-aided Detection System for Breast Masses on Digital Tomosynthesis Mammograms: Preliminary Experience Radiology. ,vol. 237, pp. 1075- 1080 ,(2005) , 10.1148/RADIOL.2373041657
William E. Gillanders, Thalachallour Mohanakumar, Progress in the Development of a Breast Cancer Vaccine: Mammaglobin A as an Attractive Target for Vaccine Therapy Breast Diseases: A Year Book Quarterly. ,vol. 17, pp. 26- 28 ,(2006) , 10.1016/S1043-321X(06)80323-1
I. Reiser, R. M. Nishikawa, M. L. Giger, T. Wu, E. Rafferty, R. H. Moore, D. B. Kopans, Computerized detection of mass lesions in digital breast tomosynthesis images using two- and three dimensional radial gradient index segmentation. Technology in Cancer Research & Treatment. ,vol. 3, pp. 437- 441 ,(2004) , 10.1177/153303460400300504
C-Y Kan, B J Iacopetta, J S Lawson, N J Whitaker, Identification of human papillomavirus DNA gene sequences in human breast cancer. British Journal of Cancer. ,vol. 93, pp. 946- 948 ,(2005) , 10.1038/SJ.BJC.6602778
Vimla Band, Deborah Zajchowski, Victoria Kulesa, Ruth Sager, None, Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 463- 467 ,(1990) , 10.1073/PNAS.87.1.463